🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 22 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/09/1988 | 9,10 | 9,12 | 9,05 | 9,08 | -0,44% | 0,87% | 1.565.083 |
| 23/09/1988 | 9,12 | 9,14 | 9,01 | 9,12 | -0,22% | 1,53% | 2.947.186 |
| 22/09/1988 | 9,30 | 9,32 | 9,12 | 9,14 | -1,71% | 2,14% | 5.394.475 |
| 21/09/1988 | 9,26 | 9,36 | 9,20 | 9,30 | +1,30% | 1,72% | 8.377.502 |
| 20/09/1988 | 9,20 | 9,22 | 9,16 | 9,18 | +0,00% | 0,65% | 2.678.059 |
| 19/09/1988 | 9,28 | 9,28 | 9,16 | 9,18 | -1,49% | 1,29% | 3.584.160 |
| 16/09/1988 | 9,22 | 9,36 | 9,20 | 9,32 | +0,86% | 1,72% | 8.967.946 |
| 15/09/1988 | 9,30 | 9,36 | 9,22 | 9,24 | -0,64% | 1,50% | 5.112.144 |
| 14/09/1988 | 9,26 | 9,32 | 9,22 | 9,30 | +1,30% | 1,07% | 5.802.566 |
| 13/09/1988 | 9,18 | 9,20 | 9,10 | 9,18 | +0,00% | 1,08% | 4.154.482 |
| 12/09/1988 | 9,18 | 9,24 | 9,12 | 9,18 | +0,00% | 1,30% | 5.634.677 |
| 09/09/1988 | 9,05 | 9,22 | 8,97 | 9,18 | +1,54% | 2,86% | 4.542.451 |
| 08/09/1988 | 9,03 | 9,08 | 9,01 | 9,05 | +0,00% | 0,88% | 3.631.320 |
| 07/09/1988 | 8,99 | 9,05 | 8,95 | 9,05 | +0,89% | 1,11% | 4.011.115 |
| 06/09/1988 | 8,87 | 8,97 | 8,85 | 8,97 | +1,58% | 1,35% | 3.834.422 |
| 02/09/1988 | 8,71 | 8,93 | 8,69 | 8,83 | +2,30% | 2,74% | 5.589.403 |
| 01/09/1988 | 8,65 | 8,71 | 8,57 | 8,63 | -1,14% | 1,61% | 5.281.291 |
| 31/08/1988 | 8,91 | 8,93 | 8,71 | 8,73 | -1,57% | 2,45% | 3.191.789 |
| 30/08/1988 | 8,89 | 8,93 | 8,85 | 8,87 | -0,22% | 0,89% | 3.042.763 |
| 29/08/1988 | 8,75 | 8,89 | 8,67 | 8,89 | +0,90% | 2,50% | 2.654.165 |
| 26/08/1988 | 8,71 | 8,83 | 8,71 | 8,81 | +0,68% | 1,37% | 2.395.728 |
| 25/08/1988 | 8,77 | 8,79 | 8,71 | 8,75 | -1,12% | 0,91% | 2.966.050 |
| 24/08/1988 | 8,73 | 8,85 | 8,71 | 8,85 | +2,06% | 1,59% | 2.928.322 |
| 23/08/1988 | 8,81 | 8,85 | 8,67 | 8,67 | -0,91% | 2,03% | 3.696.715 |
| 22/08/1988 | 8,89 | 8,89 | 8,73 | 8,75 | -1,79% | 1,79% | 4.696.507 |
| 19/08/1988 | 8,93 | 9,03 | 8,83 | 8,91 | +0,22% | 2,23% | 5.092.651 |
| 18/08/1988 | 8,83 | 8,97 | 8,81 | 8,89 | +1,36% | 1,80% | 6.409.358 |
| 17/08/1988 | 8,79 | 8,83 | 8,73 | 8,77 | +0,68% | 1,13% | 3.464.688 |
| 16/08/1988 | 8,59 | 8,81 | 8,55 | 8,71 | +1,39% | 3,01% | 5.271.230 |
| 15/08/1988 | 8,69 | 8,73 | 8,55 | 8,59 | -0,69% | 2,06% | 2.392.584 |